Jeffrey A. Lieberman – författare

A world-renowned psychiatrist reveals the fascinating story of psychiatry''s origins, demise and redemption. Psychiatry has come a long way since the days of chaining ''lunatics'' in cold cells and parading them as freakish marvels before a gaping public. But, as Jeffrey Lieberman reveals in his extraordinary and eye-opening book, the path to legitimacy for ''the black sheep of medicine'' has been anything but smooth. In SHRINKS, Dr Lieberman traces the field from its birth as a mystic pseudo-science through its adolescence as a cult of ''shrinks'' to its late blooming maturity since the Second World War as a science-driven profession that saves lives. With fascinating case studies and portraits of the luminaries of the field, from Sigmund Freud to Eric Kandel, SHRINKS is a gripping and illuminating read. It is also an urgent call-to-arms to dispel the stigma surrounding mental illness and to start treating it as a disease rather than a state of mind.

This book challenges professional and public misconceptions of schizophrenia as an illness with intractable symptoms and inexorable mental deterioration, educating clinicians and researchers on the effectiveness of treatment to change the course of or prevent the onset of illness.

The authors illustrate such effectiveness through fifteen case studies examining psychosis in diverse clients. These case studies are divided into the three phases of the illness—prodromal/clinical high risk, first-episode, chronic, and treatment-refractory—with accompanying analyses of the causes, symptoms, interventions and treatments. By depicting patients at different clinical stages of the illness, with accompanying explanations of how they got to that point, what might have been done to avoid – or has been done to achieve – this outcome, the reader will gain an appreciation of the nature of the illness and for the therapeutic potential of currently available treatments.

Readers will learn about the various clinical aspects of schizophrenia and treatment including diagnosis, prognosis, clinical presentation, suicide risk, cognitive deficits, stigma, medication management, and psychosocial interventions.

This book challenges professional and public misconceptions of schizophrenia as an illness with intractable symptoms and inexorable mental deterioration, educating clinicians and researchers on the effectiveness of treatment to change the course of or prevent the onset of illness.

The authors illustrate such effectiveness through fifteen case studies examining psychosis in diverse clients. These case studies are divided into the three phases of the illness—prodromal/clinical high risk, first-episode, chronic, and treatment-refractory—with accompanying analyses of the causes, symptoms, interventions and treatments. By depicting patients at different clinical stages of the illness, with accompanying explanations of how they got to that point, what might have been done to avoid – or has been done to achieve – this outcome, the reader will gain an appreciation of the nature of the illness and for the therapeutic potential of currently available treatments.

Readers will learn about the various clinical aspects of schizophrenia and treatment including diagnosis, prognosis, clinical presentation, suicide risk, cognitive deficits, stigma, medication management, and psychosocial interventions.

Written by well-known and highly regarded experts from around the world, it takes a patient-centered approach making it an indispensable resource for all those involved in the care of patients with psychiatric disorders.

For this new edition, the section on the Neuroscientific Foundations of Psychiatry has been completely revised, with a new author team recruited by Section Editors Jonathan Polan and Eric Kandel.  The final section, Special Populations and Clinical Settings, features important new chapters on today’s most urgent topics, including the homeless, restraint and geriatric psychiatry.

Key features include:

The chapter on Cognitive Behavioral Therapies by Edward Friedman, Michael Thase and Jesse Wright is freely available.  Please click on Read Excerpt 2 above to read this superb exposition of these important therapies.

The new edition of The American Psychiatric Association Publishing Textbook of Schizophrenia plumbs the current state of knowledge about the disorder''s origin, nature, and treatment in a comprehensive, authoritative, and thoroughly revised text. Schizophrenia is one of the leading causes of disability worldwide and remains among the most challenging and disheartening disorders confronting psychiatrists and other mental health care providers because of its profound effects on patient functioning, its onset just as young adults are launching their lives, and the limitations of current pharmacological treatments. Designed to bring the reader up to date on the latest research, this new edition represents a complete overhaul of the previous text, with a new structure, new chapters, and new contributors. Subjects such as genetics and neurobiology, distinguished by rapid advancements in knowledge, are explored in depth, as are new models of service delivery and psychosocial treatments that are making a significant difference in patients'' lives. Foundational information on the epidemiology, etiology, and psychopathology of the illness is presented clearly and cogently, emphasizing research conducted over the last decade. Theories regarding the pathophysiological basis of the disorder, including genetic, molecular, and neurocircuitry models, are examined in detail.

Other noteworthy topics include: • Cultural variations, examining how culture influences the presentation of schizophrenia from the perspective of the experts in cultural psychiatry who developed the DSM-5 Cultural Formulation Interview• Service delivery models, including assertive community treatment, critical time intervention, coordinated specialty care for early psychosis, and integrated dual diagnosis, informing clinicians about options for providing treatment to individuals with schizophrenia• Advances in the existing pharmacological treatments, including use of adjunctive medications and combinations of antipsychotics, which, in the absence of new drug therapies, is indispensable knowledge• A review of the promising field of neuromodulation• Evaluation and treatment of comorbidities, such as depression, obsessive-compulsive disorder, and substance use disorders, vital information because over half of people with schizophrenia have at least one co-occurring behavioral health disorder• Individual- and family-centered care, which presents the rationale and evidence for actively involving patients and family members in interventions and decision-making about treatments Designed for ease of use, The American Psychiatric Association Publishing Textbook of Schizophrenia furnishes evidence-based and cutting-edge knowledge for the next generation of students, trainees, and clinicians.